Home / Share Price Target / Bafnaph
Bafna Pharmaceuticals Share Price Target 2024, 2025, 2026 to 2039 With Charts
Bafna Pharmaceuticals Limited | |||
 | Symbol: BAFNAPH | ||
| Price: ₹80 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Bafna Pharmaceuticals Brief Company Overview
- 1.1: Bafna Pharmaceuticals Limited: A Pharmaceutical Powerhouse
- 1.1.1: Diverse Product Portfolio
- 1.1.2: Industry Reputation and Commitment
- 1.1.3: Global Reach
- 1.2: Bafna Pharmaceuticals Financial Performance
- 1.2.1: Is Bafna Pharmaceuticals A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Bafna Pharmaceuticals Share Price Target For 2024
- 2.1.1: Bafna Pharmaceuticals Share Price Target Table For 2024
- 2.1.2: Summary: Bafna Pharmaceuticals Share Price Prediction For 2024
- 2.2: Bafna Pharmaceuticals Share Price Target For 2025
- 2.2.1: Bafna Pharmaceuticals Share Price Target Table For 2025
- 2.2.2: Summary: Bafna Pharmaceuticals Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Bafna Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Bafna Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Bafna Pharmaceuticals Past Performance
Bafna Pharmaceuticals Brief Company Overview
Bafna Pharmaceuticals Limited: A Pharmaceutical Powerhouse
Established in 1981, Bafna Pharmaceuticals Limited has emerged as a leading manufacturer and exporter of finished pharmaceutical formulations in India.
Diverse Product Portfolio
- Delayed and sustained release tablets
- Chewable tablets
- Orally disintegrating tablets
Industry Reputation and Commitment
Bafna Pharmaceuticals has earned a strong reputation in the industry for its quality products and commitment to innovation. The company is a subsidiary of SRJR Lifesciences LLP, ensuring stability and growth.
Global Reach
Bafna Pharmaceuticals exports its products to various countries, establishing a presence in the global pharmaceutical market.
Bafna Pharmaceuticals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 194.62 Crore | Market valuation of Bafna Pharmaceuticals's shares. |
| Revenue (TTM) | 143.8 Crore | Total revenue generated by Bafna Pharmaceuticals over the past twelve months. |
| Net Income (TTM) | +27.32 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -0.7% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 0.19% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -20.6% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 30.17 | Company's total debt divided by total shareholder equity. |
| Total Debt | 24.38 Crore | Sum of Bafna Pharmaceuticals's current & long-term financial obligations. |
| Total Cash | 1.39 Crore | Total amount of liquid funds available to Bafna Pharmaceuticals. |
| Beta | 0.46 | Beta is less than 1 indicating that the Bafna Pharmaceuticals's price is less volatile than the market. |
Is Bafna Pharmaceuticals A Good Buy For Long Term?
Bafna Pharmaceuticals, a small-cap stock with a market capitalization of ₹191.59 crore, presents a mixed picture for long-term investors. While its revenue of ₹143.8 crore is significant, a net profit of only ₹27.32 lakh (0.19% profit margin) and a substantial debt of ₹24.38 crore raise serious concerns. Negative returns over the past 3 months (-6.98%), 6 months (-15.62%), and 12 months (-7.25%) further fuel these concerns. Although past 5-year returns show a substantial increase (592.64%), the recent performance suggests it's not a good buy for the long term at this time. Further investigation is needed before considering an investment.
To predict the Bafna Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Bafna Pharmaceuticals Share Price Target For 2024
The line chart displays the monthly closing prices of Bafna Pharmaceuticals with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bafna Pharmaceuticals shares in 2024, see the table below.
Bafna Pharmaceuticals Share Price Target Table For 2024
| Bafna Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 82.22 (+2.77%) | Fibonacci Extension Level 123.6% |
| 2024 Target 2 | 81.34 (+1.67%) | Price Action: 28 Oct 2024 High |
| 2024 Target 1 | 80.42 (+0.52%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 80.00 | Bafna Pharmaceuticals's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 79.84 (-0.2%) | Price Action: 24 Oct 2024 High |
| Stop Loss 2 | 79.00 (-1.25%) | Price Action: 13 Nov 2024 Low |
| Stop Loss 3 | 78.20 (-2.25%) | Price Action: 18 Oct 2024 Low |
Summary: Bafna Pharmaceuticals Share Price Prediction For 2024
In summary, Bafna Pharmaceuticals has declined by ₹-12.00, recording a notable -13.04% decrease from 1st January 2024 to 22 Nov 2024. Despite the setback, our analysis of Bafna Pharmaceuticals for 2024 predicts an additional rise of 0.52% to 2.77% by the end of 2024 with three potential targets T1: 80.42, T2: 81.34, T3: 82.22. Stop Loss at SL1: 79.84, SL2: 79.00, SL3: 78.20.
Bafna Pharmaceuticals has a 52-week high of ₹113.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹73.25, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Bafna Pharmaceuticals.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Bafna Pharmaceuticals Share Price Target For 2025
The line chart displays the monthly closing prices of Bafna Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bafna Pharmaceuticals shares in 2025, see the table below.
Bafna Pharmaceuticals Share Price Target Table For 2025
| Bafna Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 103.93 (+29.91%) | Price Action: Chart |
| 2025 Target 2 | 101.99 (+27.48%) | Price Action: Chart |
| 2025 Target 1 | 100.98 (+26.22%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 80.00 | Bafna Pharmaceuticals's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 74.89 (-6.39%) | Price Action: Chart |
| Stop Loss 2 | 74.14 (-7.33%) | Price Action: Chart |
| Stop Loss 3 | 72.81 (-8.99%) | Price Action: Chart |
Summary: Bafna Pharmaceuticals Share Price Prediction For 2025
In summary, Bafna Pharmaceuticals has declined by ₹-12.00, recording a notable -13.04% decrease from 1st January 2024 to 22 Nov 2024. Despite the setback, our analysis of Bafna Pharmaceuticals for 2025 predicts an additional rise of 26.22% to 29.91% by the end of 2025 with three potential targets T1: 100.98, T2: 101.99, T3: 103.93. Stop Loss at SL1: 74.89, SL2: 74.14, SL3: 72.81.
Bafna Pharmaceuticals has a All-Time high of ₹233.55, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹73.25, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Bafna Pharmaceuticals, we have created a specific page for that check here: Bafna Pharmaceuticals Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Bafna Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Bafna Pharmaceuticals share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 1.96% over the next 15 years.
For complete year by year Bafna Pharmaceuticals long term share price target from 2024, 2025 to 2039 check the below table.
Bafna Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Bafna Pharmaceuticals Target | YoY Change % |
|---|---|---|
| 2024 | ₹80 | [Current Price] |
| 2024 | ₹72.45 | -9.43% |
| 2025 | ₹65.15 | -10.09% |
| 2026 | ₹58.09 | -10.84% |
| 2027 | ₹53.22 | -8.39% |
| 2028 | ₹59.36 | 11.53% |
| 2029 | ₹57.83 | -2.58% |
| 2030 | ₹53.98 | -6.66% |
| 2031 | ₹91.9 | 70.24% |
| 2032 | ₹87.75 | -4.52% |
| 2033 | ₹103.43 | 17.86% |
| 2034 | ₹108.61 | 5% |
| 2035 | ₹91.32 | -15.92% |
| 2036 | ₹94.77 | 3.77% |
| 2037 | ₹90.47 | -4.54% |
| 2038 | ₹106.61 | 17.84% |
| 2039 | ₹95.1 | -10.8% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Bafna Pharmaceuticals Past Performance
- In 2012, Bafna Pharmaceuticals opening price was ₹47.75
- As of Fri 22 Nov 2024 the price stands at ₹80.
- This represents a Compound Annual Growth Rate (CAGR) of 4.05%.
- In 12 years, an investment of 10,000 would have become ₹16,753.92.
As we wrap up, we hope you like our study on Bafna Pharmaceuticals share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
